The therapeutic potential of GPR119 agonists for type 2 diabetes

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.3, 2012-03, pp. : 321-328

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus: Benefits and Challenges

Current Drug Targets, Vol. 17, Iss. 11, 2016-07 ,pp. : 1292-1300

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes

By Drucker DJ

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 1, 2003-01 ,pp. : 87-100

Informa Healthcare

Access to resources Recommend Favorite

Miglitol: A Review of its Therapeutic Potential in Type 2 Diabetes Mellitus

By Scott L.J. Spencer C.M.

Drugs, Vol. 59, Iss. 3, 2000-03 ,pp. : 521-549

Adis International

Access to resources Recommend Favorite

Therapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes

By Komers R. Komersova K.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2601-2617

Informa Healthcare

Access to resources Recommend Favorite

Sodium-Glucose Co-Transport Inhibitors: Progress and Therapeutic Potential in Type 2 Diabetes Mellitus

By Neumiller Joshua J.

Drugs, Vol. 70, Iss. 4, 2010-03 ,pp. : 377-385

Adis International

Access to resources Recommend Favorite